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ORIGINAL ARTICLES: EARLY PREGNANCYPrevalences and pregnancy outcome
of vanishing twin pregnancies
achieved by in vitro fertilization
versus natural conception
Virag Marton, M.D.,a Janos Zadori, M.D., Ph.D.,b Zoltan Kozinszky, M.D., Ph.D.,c
and Attila Kereszturi, M.D., Ph.D.a
a Department of Obstetrics and Gynecology and b Center for Assisted Reproduction, Kaali Institute, University of Szeged,
Szeged, Hungary; and c Department of Obstetrics and Gynecology, Blekinge Hospital, Karlskrona, SwedenObjective: To evaluate whether vanishing twin (VT) pregnancies achieved by in vitro fertilization and intracytoplasmic sperm injection
(IVF–ICSI) had a more adverse perinatal outcome than those after natural conception.
Design: Longitudinal, retrospective cohort study.
Setting: Tertiary university hospital.
Patient(s): Three hundred and six (78 after IVF–ICSI and 228 after natural conception) VT pregnancies over a 22-year period, with VT
cases matched to primarily singleton controls.
Intervention(s): None.
Main Outcome Measure(s): Obstetric and neonatal outcome data.
Result(s): The incidence of VT was statistically signiﬁcantly higher after natural conception (18.2% of twins) than after IVF–ICSI
(12.6% of twins). The odds of VT in pregnancies complicated with pregestational or gestational diabetes were disproportionally higher
in IVF–ICSI cases than in spontaneously conceived VT pregnancies (adjusted odds ratio [AOR]: 0.80 vs. 3.10 and 1.00 vs. 1.07, respec-
tively). Previous induced abortion (AOR 1.34) or second-trimester fetal loss (AOR 3.3) increased the risk of VT pregnancies after
spontaneous conception. Gestational diabetes mellitus in both the previous (AOR 5.41) and the present (AOR 2.3) pregnancy as well
as chronic maternal diseases (AOR 3.5) and placentation anomalies all represented independent risk factors for VT after IVF–ICSI.
Conclusion(s): Vanishing twin pregnancies had a lower prevalence and a worse perinatal outcome after IVF–ICSI as compared with those
of their spontaneously conceived counterparts. (Fertil Steril 2016;106:1399–406.2016byAmericanSociety for ReproductiveMedicine.)
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fertilization-versus-natural-conceptionT he increasing burden of infertilityhas led to an expanded rate ofuse of in vitro fertilization (IVF)
and intracytoplasmic sperm injection
(ICSI) (1), which has in turn enhanced
twin conception rates and, presumably,
the incidence of vanishing twin (VT)
pregnancies (2). Double-embryo transfer
is still routine in a number of countries
(3) even though the beneﬁt of a single-Received April 1, 2016; revised July 7, 2016; accepted
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becomeevident (4). Some studies have re-
ported that the obstetric outcome of the
survivors of VT pregnancies after the
IVF–ICSI technique is in between those
of singletons and twins (5–9), whereas
La Sala et al. (10) demonstrated that it is
comparable to those of singletons.
The incidenceofVTpregnancies var-
ies between 10%and 39% in pregnanciesJuly 18, 2016; published online August 24, 2016.
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Medicine, Published by Elsevier Inc.resulting from IVF–ICSI (2,5,7,8,10–13),
but the exact prevalence of VT after
spontaneous conception has remained
unclear (6, 14, 15). The etiology of the
VT phenomenon is still obscure;
however, placental degeneration (16)
and chromosomal abnormality in the
vanishing embryo (17) have been
conﬁrmed pathologically. Other possible
causes, including inappropriate site for
implantation, placental ‘‘crowding,’’
intrauterine bleeding, and chronic
maternal diseases have been proposed
(6,18–21).
We hypothesized that there is a dif-
ference in perinatal outcomes between
VT pregnancies after artiﬁcial concep-
tion and those after natural conception,1399
ORIGINAL ARTICLE: EARLY PREGNANCYpossibly reﬂecting the potential differences between underly-
ing pathomechanisms. We compared obstetric and neonatal
outcomes between the survivors of VT pregnancies and
matched singletons originating from single gestations after
an IVF–ICSI procedure and after natural conception. Our pur-
pose was to demonstrate the effect of the IVF–ICSI technique
on the VT phenomenon and to determine the prevalence of VT
pregnancies in iatrogenic and spontaneous twins.MATERIALS AND METHODS
A retrospective cohort study was conducted at the Depart-
ment of Obstetrics and Gynecology, University of Szeged.
The study included data abstracted from the medical database
on VT pregnancies and matched controls between January 1,
1994, and November 30, 2014, that were subsequently deliv-
ered at our department. All IVF–ICSI treatments were per-
formed at a single IVF center. In Hungary, sonographic
conﬁrmation of all pregnancies is obtained at 5 to 8 weeks
with a repeat examination at 11 to 14 weeks to scan nuchal
translucency systematically, thus providing a unique oppor-
tunity to identify all VT cases.
A total of 65,237 deliveries were singletons, 1,563 were
twins, and 306 pregnancies were identiﬁed as VT syndrome
cases, based on a review of all routine ﬁrst-trimester scans,
thus demonstrating a total rate of 4.69 out of 1,000 total
pregnancies. Vanishing twin was diagnosed in cases where
either [1] two viable embryos with cardiac activity with
spontaneous reduction of one embryo or [2] a single viable
embryo and an additional gestational sac were established
before 14 weeks of gestation (14). A total of 78 VT cases re-
sulting from 617 IVF with or without ICSI dichorionic twins
(12.6%) and 228 VT cases were naturally conceived for 1,252
spontaneous dichorionic twin pregnancies (18.2%)
(P¼ .002). We found that 36.8 VTs occurred out of 1,000
IVF–ICSI live births compared with a rate of 3.6/1,000 live
births after natural conception (P< .001). All the women
with VT pregnancies after IVF–ICSI underwent a double-
embryo transfer procedure. All cases of single fetal loss at
later gestation (>14 weeks) or pregnancies after ovulation
induction/insemination were excluded from the analyses.
Monochorionic twins (determined through the absence of a
‘‘twin peak’’ sign in sonography) and women undergoing
iatrogenic reduction were also excluded.
For each case, three controls were matched according to
the following criteria: singleton pregnancies started as
singleton gestations achieved by natural conception or IVF–
ICSI, which were equal in maternal age, previous gravidity,
parity, and prepregnancy body mass index (BMI) and deliv-
ered after VT pregnancies in chronologic order. Demographic
data, maternal characteristics, and obstetric and neonatal
outcomes were retrieved from obstetric and neonatal data-
bases and were exported to Microsoft Excel.
Vanishing twin cases were gathered from the sonogra-
phy database at our department. Gestational age was estab-
lished by the day of embryo transfer for the IVF–ICSI group
and by sonographic measurement of the embryo in the ﬁrst
trimester for the spontaneous conception group. Intrauterine
growth restriction (IUGR) was diagnosed when the growth1400curve had declined signiﬁcantly below 10th percentile, re-
sulting in a small fetus for pathological reasons. We deﬁned
birth weight as <2,500 grams for low birth weight and
<1,500 grams for very low birth weight. Prematurity was
deﬁned as delivery at <37 weeks of gestation, and very pre-
mature birth was classiﬁed as birth at <32 weeks. The pre-
pregnancy BMI registered at the initial visit during
prenatal care was calculated as the body weight (kg) per
height (m2). Chronic maternal diseases (i.e., essential hyper-
tension, cardiac, autoimmune and endocrine diseases, pre-
existing diabetes, and thromboembolic diseases) as risk
factors for miscarriage were categorized into one variable
to better interpret the statistical analyses. The demographic
and obstetric history data and prevalence of chronic
maternal diseases were analyzed. The following antepartum
and intrapartum complications were examined: gestational
diabetes mellitus (GDM), preeclampsia, placental abruption,
placenta previa, retained placenta, and surgical delivery.
Neonatal outcome measurements were as follows: gesta-
tional age, prematurity, birth weight, fetal growth distur-
bances (IUGR, very low birth weight, low birth weight),
neonatal intensive care unit (NICU) admission, male sex,
and congenital abnormalities.
All statistics were calculated using SPSS 22 (SPSS Inc.).
The nonparametric design of the continuous variables was
veriﬁed with the Shapiro-Wilk test. Vanishing twin was
the major exposure variable. Univariate comparisons be-
tween VT pregnancies and controls both for IVF–ICSI and
spontaneously conceived pregnancies were assessed with
the Mann-Whitney U probe for continuous variables. Cate-
gorical variables were compared between the subgroups us-
ing chi-square tests, and odds ratios (OR) and Cornﬁeld 95%
conﬁdence intervals (CIs) were also calculated. The resultant
ORs for IVF and spontaneous pregnancies were compared
with Mantel–Haenszel tests, providing an estimate of the ef-
fect of assisted reproductive techniques on the VT phenom-
enon. Multivariable logistic regression was performed to
evaluate the factors determining VT pregnancies in both
the IVF–ICSI and the spontaneous groups separately. Non-
VT pregnancies were used as the reference group.
The multivariable dependence of the target variable on
both categorical and continuous data were analyzed using lo-
gistic regression with stepwise (forward) model selection
based on the likelihood ratio criterion (Pin¼ .05; Pout¼ .10).
All the prepregnancy, maternal characteristics, and perinatal
outcome variables represented independent factors. All the
variables were adjusted for maternal age. Body mass index,
parity, chronic maternal diseases, and obstetric history data,
including miscarriage, termination of pregnancy, fetal loss
in the second trimester, hypertensive disorder, prematurity,
and IUGR in previous pregnancies constituted confounding
risk factors.
The adjusted OR was also calculated with 95% CI. The
two-tailed statistical signiﬁcance level was set at 5%, and P
values were adjusted using a Holm–Bonferroni correction
for multiple comparisons (Mann-Whitney U tests and logistic
regression analyses). The study was approved by the ethics
committee of the University of Szeged, and the need for
informed consent was waived.VOL. 106 NO. 6 / NOVEMBER 2016
TABLE 1
Baseline maternal characteristics and obstetric history in pregnancies complicated with vanishing twins andmatched controls presented at the Department of Obstetrics and Gynecology, University of
Szeged, between January 1, 1994, and November 30, 2014.
Characteristics
IVF/ICSI pregnancies Spontaneously conceived pregnancies
P valueb
Vanishing
twin
(n[ 78)
Matched
singleton
(n[ 234)
P valuea
Unadjusted
OR (95% CI)a
Adjusted
OR (95% CI)a
Vanishing
twin
(n[ 228)
Matched
singleton
(n[ 684)
P valuea
Unadjusted
OR (95% CI)a
Adjusted
OR (95% CI)an % n % n % n %
Age (mean  SD) (y)c 34.8  3.71 35.4  3.74 .46 0.96 (0.90–1.03) 0.89 (0.86–0.94) 33.20  4.38 33.30  4.46 .85 0.99 (0.96–1.03) 0.91 (0.78–1.14)
No. of children
(mean  SD)c
0.15  0.37 0.15  0.36 1.00 1.00 (0.49–2.04) 1.00 (0.65–1.81) 0.71  0.83 0.74  0.85 .86 0.96 (0.81–1.15) 0.87 (0.77–1.34)
Prepregnancy
BMI (kg/m2)c
23.22  3.10 23.54  3.96 .53 0.94 (0.87–1.01) 0.93 (0.85–1.06) 24.27  3.44 24.53  4.90 .30 1.01 (0.98–1.05) 1.00 (0.95–1.09)
Weight gain during
pregnancy
12.54  3.95 11.85  4.87 .38 0.99 (0.96–1.01) 1.00 (0.91–1.08) 12.34  5.08 13.24  5.29 .39 0.97 (0.96–1.02) 0.95 (0.91–1.05)
Smoking during
pregnancy
0 0 0 0 –d –d –d 6 2.6 36 5.3 .67 0.49 (0.20–1.17) 0.33 (0.11–1.45) .92
Chronic maternal
diseasese
15 19.2 18 7.7 .009 2.86 (1.36–6.00) 1.10 (1.10–2.20) 54 23.7 90 13.2 < .001 2.05 (1.41–2.99) 2.01 (1.56–2.67) .97
Previous pregnancyf
Total no. multiparous IVF Total no. multiparous
spontaneously conceived
Vanishing
twin
(n[ 18)
Matched
singleton
(n[ 54)
Vanishing
twin
(n[ 144)
Matched
singleton
(n[ 414)
n % n % n % n %
Miscarriage in ﬁrst
trimester
18 100 54 100 –d –d –d 66 45.8 174 42 .44 1.17 (0.80–1.71) 1.34 (0.80–2.82) .98
Termination of
pregnancies
in ﬁrst trimester
0 0 0 0 –d –d –d 66 45.8 144 34.8 .02 1.59 (1.08–2.33) 1.34 (1.10–2.82) .51
Fetal loss in
second trimester
0 0 0 0 –d –d –d 18 12.5 18 4.3 .001 3.14 (1.59–6.23) 3.32 (1.80–7.82) .72
Preterm birth 0 0 6 11.1 .33 0.89 (0.81–0.97) (0.66)
(0.54–0.79)
12 8.3 24 5.8 .32 1.48 (0.72–3.04) 1.77 (0.90–2.24) .98
IUGR 0 0 0 0 –d –d –d 18 12.5 0 0 < .001 1.14 (1.07–1.21) 1.22 (1.20–1.34) .59
Hypertensive
disorders
0 0 0 0 –d –d –d 0 0 24 5.8 .001 0.94 (0.92–0.97) 0.12 (0.10–0.44) .82
GDM 6 33.3 6 11.1 .06 4.00 (1.09–14.6) 3.1 (1.88–10.1) 6 4.2 22 5.3 .66 0.78 (0.31–1.95) 1.22 (0.91–1.29) .98
Note: All variables were adjusted for age, bodymass index, parity, chronic maternal diseases, and obstetric history data: miscarriage, termination of pregnancy, fetal loss in the second trimester, hypertensive disorder, prematurity, and IUGR in previous pregnancies. BMI¼
body mass index; CI ¼ conﬁdence interval; GDM ¼ gestational diabetes mellitus; ICSI ¼ intracytoplasmic sperm injection; IUGR ¼ intrauterine growth restriction; IVF ¼ in vitro fertilization; OR ¼ odds ratio; SD ¼ standard deviation.
a P value, odds ratio, and 95% conﬁdence interval for comparison of categorical data with Fisher's exact test or chi-square test.
b P value for the Mantel-Haenszel test.
c Continuous variables displayed as mean  standard deviation (SD). Comparison of continuous data with Mann-Whitney U test.
d Statistical analysis was not meaningful.
e Chronic maternal diseases (i.e., essential hypertension, cardiac, autoimmune or endocrine diseases, pregestational diabetes, and thromboembolic diseases) were grouped together into one variable because they are all risk factors of miscarriage.
f Only women with previous pregnancies were counted.
Marton. Pregnancy outcome of vanishing twin. Fertil Steril 2016.
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ORIGINAL ARTICLE: EARLY PREGNANCYRESULTS
Table 1 presents the patterns for maternal characteristics in
the VT pregnancies and their matched singleton pregnancies
after IVF–ICSI and natural conception. The two IVF–ICSI
subgroups were comparable with regard to maternal age;
similar BMI and weight gain at delivery were observed in
those two groups. The number of children did not statisti-
cally signiﬁcantly differ between the two IVF–ICSI study
groups. Maternal age was higher for the IVF–ICSI pregnan-
cies compared with the spontaneously conceived pregnan-
cies. The BMI at delivery was statistically signiﬁcantly
lower among the spontaneous VT pregnant women
(P¼ .049) than their matched controls, whereas weight
gain during pregnancy was similar in the naturally
conceived subgroups. All the women in the IVF–ICSI sub-
groups were nonsmokers, and negligibly small proportions
smoked in the spontaneously conceived subgroups.
All chronic maternal diseases categorized as a single
variable were statistically signiﬁcantly more prevalent
among VT pregnancies even after controlling for relevant
cofactors; however, mode of conception was not a distin-
guishable determinant. Previous miscarriage in the ﬁrst
trimester was not different in the VT and non-VT pregnan-
cies due to the matching of our cohorts, but termination of
pregnancy and second-trimester fetal loss previously came
into prominence as risk factors for single fetal loss. Intra-
uterine growth restriction in a previous pregnancy was asso-
ciated with a statistically signiﬁcantly higher risk of VT in
the spontaneous group. In contrast, the occurrence of hyper-
tensive disorders during any previous pregnancy was statis-
tically signiﬁcantly higher in the non-VT pregnancies in the
spontaneous group. There were no recorded IUGR or hyper-
tensive disorders in the previous IVF–ICSI pregnancies. A
history of diabetes during a previous gestation was an inde-
pendent contributing factor to VT pregnancy in IVF–ICSI
pregnancies after controlling for confounders by multivar-
iate analysis, but it was not a statistically signiﬁcant deter-
minant in the spontaneous conception group. Preterm birth
in the previous pregnancy did not inﬂuence the occurrence
of VT.
Table 2 provides an overview of the pregnancy charac-
teristics and intrapartum complications in the subgroups.
The average gestational length at the time of vanishing in
the IVF–ICSI group was 9.86  2.06 weeks, whereas VT
was conﬁrmed at 8.86  2.70 weeks in the spontaneous
conception group (P¼ .057) (data not shown). A substan-
tially higher percentage of women with VT pregnancies
(OR 3.0; 95% CI, 1.6–5.6) developed GDM compared with
the non-VT pregnancies after assisted reproduction
(P¼ .01); it was inversely less common among their naturally
conceived counterparts (OR 0.46; 95% CI, 0.2–1.1). Even af-
ter adjusting for confounders, IVF–ICSI was statistically
signiﬁcantly more associated with GDM, and this was
more pronounced for VT cases (P< .001) due to its very
low occurrence in the spontaneous conception group.
Similarly, pregestational diabetes mellitus represented
an increased risk for VT in IVF–ICSI (adjusted OR [AOR]
1.07; 95% CI, 1.04–1.2), but it was not a distinguishable1402 VOL. 106 NO. 6 / NOVEMBER 2016
Fertility and Sterility®factor for the spontaneously conceived subgroups (AOR 1.00;
95% CI, 0.94–1.00), thus exhibiting a statistically signiﬁcant
difference between the IVF–ICSI and non-IVF pregnancies
(P< .001). Preeclamptic pregnancies in VT subgroups after
IVF–ICSI (AOR 1.6; 95% CI, 0.7–6.1) and spontaneous
conception (AOR 1.00; 95% CI, 0.8–1.8) showed similar pro-
portions compared with matched controls. Chronic hyperten-
sion was largely infrequent in all subgroups (data not shown).
Placenta previa was almost statistically signiﬁcantly more
prevalent in VT pregnancies in the IVF–ICSI group (P¼ .08,
AOR 3.8; 95% CI, 1.0–9.3) compared with the non-VT
subgroup.
Although the spontaneous VT pregnancies were statisti-
cally signiﬁcantly more likely to be complicated by placental
abruption than the matched controls (AOR 10.6; 95% CI, 2.5–
39), this was less marked after IVF–ICSI (AOR 3.6; 95% CI,
1.5–9). This difference became more pronounced after con-
trolling for confounders. Retained placenta exhibited a mark-
edly higher rate in IVF–ICSI VT pregnancies (AOR 7.2; 95%CI,
3.1–19) compared with matched controls or spontaneous
pregnancies (AOR 0.67; 95% CI, 0.3–1.2). The incidence of
surgical delivery was lower among the IVF–ICSI pregnancies
(though not statistically signiﬁcant) compared with the spon-
taneously conceived counterparts.
Table 3 shows the differences in neonatal outcomes in the
case and control subgroups. Similar gestational age at time of
delivery was noted in all of the study groups. The incidence of
preterm birth was equally low among cases and controls in
both the IVF–ICSI and spontaneous subgroups. Furthermore,
there were no very preterm deliveries in the study groups. The
rate of IUGR was statistically signiﬁcantly higher in the VT
pregnancies in the spontaneous group (AOR 3.0; 95% CI,
1.8–5.2) and even more so among the IVF–ICSI cases (AOR
9.2; 95% CI, 5–22). The incidence of low birth weight was
threefold higher among the IVF–ICSI VT pregnancies and
two times higher in the naturally conceived VT pregnancies
compared with the control groups. No IVF–ICSI pregnancies
were registered as very low birth weight, and very low birth
weight was extremely scant in the spontaneous matched
controls.
The proportion of macrosomia was slightly lower in the
VT pregnancies than in the controls in the IVF–ICSI group,
but VT was associated with a statistically signiﬁcantly lower
rate of macrosomia after spontaneous conception. The VT
phenomenon resulted in a statistically signiﬁcantly higher
male sex rate in spontaneous pregnancies (AOR 1.4; 95%
CI, 1.2–1.9) but not in the IVF–ICSI group (AOR 1.1; 95%
CI, 0.8–1.9). The frequencies of neonatal intensive care unit
(NICU) admission and congenital malformation were not
more common in the VT cases.
Table 4 displays the results of the multiple logistic regres-
sion analyses, reﬂecting a different risk factor structure for VT
pregnancies achieved by IVF and natural conception. Previ-
ous and present GDM inﬂuenced the occurrence of VT in
the IVF–ICSI group with AORs of 5.41 and 2.33, respectively.
Chronic maternal disease was also a predictor, with an AOR of
3.48. The women with IVF–ICSI VT pregnancies had an over-
all 4.35-fold higher risk of placental abruption. Within the
IVF–ICSI VT group, there was a 8.00-fold higher risk of re-VOL. 106 NO. 6 / NOVEMBER 2016tained placenta and 28.2-fold higher risk of an IUGR neonate.
The risk of VT rose to 2.10-fold when a chronic maternal dis-
ease was present, and the surviving fetus had 3.65-fold higher
odds for IUGR in spontaneous VT pregnancies.DISCUSSION
The principal ﬁnding of the present study is that VT carries a
higher risk of various pregnancy complications, particularly
after the IVF–ICSI procedure. Embryonic/fetal loss at
%14 weeks has a statistically signiﬁcant effect on more
twin pregnancies after natural implantation (18.2%) than af-
ter the iatrogenic transfer of two embryos (12.6%). Early preg-
nancy loss and the VT phenomenon both share a
chromosomal defect in the conceptus (22, 23), and this
explains the idea that the artiﬁcial selection procedure for
morphologically normal embryos decreases the rate of VT
after IVF–ICSI. Further, transfer of only an intermediate-
quality embryo increases the chance of VT (23). Other possible
explanations could be the fresh embryo transfer, which is
associated with a higher perinatal risk (24). However, the VT
rates for twins after IVF–ICSI reported in the literature are be-
tween 10.8% and 39.0% (2,7,11–13).
In total, 5.2% of all singleton deliveries originated from a
VT pregnancy after assisted conception, and 0.37% did so af-
ter spontaneous single gestation. The observed difference in
the incidences of VT supports the idea that an artiﬁcial selec-
tion procedure favors embryos with high developmental po-
tential (22, 23). This raises the possible higher risk of the
implantation of a genetically impaired vanishing embryo in
naturally conceived pregnancies, as suggested earlier (22).
Further, transfer of an intermediate-quality embryo increases
the chance of VT (23). Other possible explanations for this dif-
ference are the technology itself (9) or the artiﬁcially modiﬁed
endometrium (25) in assisted reproductive cycles. Although a
moderately thick endometrium with a triple-line pattern is
more likely linked to a good clinical outcome, the decidual-
ized endometrium acts as a biosensor of embryo quality,
and the interaction between the mucosa and the embryo
with inadequate quality might coordinate the VT phenome-
non (26).
Another major ﬁnding of our study is that chronic
maternal diseases and a history of certain high-risk pregnan-
cies (e.g., IUGR and GDM) might contribute to the absorption
of a single embryo in a twin pregnancy, particularly in IVF–
ICSI pregnancies. This further emphasizes the detrimental ef-
fect of the greater prepregnancy susceptibility pertaining
directly to the inherent factors in the pathomechanism of
the VT phenomenon. Furthermore, this is in line with ﬁndings
in the literature that an unfavorable perinatal outcome is
related mostly to the infertility background in IVF–ICSI preg-
nancies, with more frequent adverse maternal characteristics
than their noninfertile counterparts (9, 27). An adverse
obstetric history comprising induced abortion and second-
trimester fetal loss as classic miscarriage-related factors is
also strongly associated with single loss in twins in sponta-
neous pregnancies.
We still noted VT as an independent risk factor for
adverse perinatal outcome after controlling for all possible1403
TABLE 3
Neonatal outcome in pregnancies complicated with vanishing twins and matched controls presented at the Department of Obstetrics and Gynecology, University of Szeged, between January 1, 1994,
and November 30, 2014.
Outcome
IVF/ICSI pregnancies Spontaneously conceived pregnancies
P valueb
Vanishing
twin (n[ 78)
Matched
singleton
(n[ 234)
P valuea
Unadjusted
OR (95% CI)a
Adjusted
OR (95% CI)a
Vanishing
twin (n[ 228)
Matched
singleton
(n[ 684)
P valuea
Unadjusted
OR (95% CI)a
Adjusted
OR (95% CI)an % n % n % n %
Gestational age
(mean  SD) (wk)c
38.41.10 38.41.32 .66 0.98 (0.80–1.20) 0.91 (0.71–1.31) 38.801.59 38.80  1.44 .91 1.01 (0.92–1.12) 1.00 (0.89–1.2)
Preterm birth 0 0 2 2.6 1.00 1.01 (1.00–1.02) 0.99 (1.00–1.03) 12 5.3 30 4.4. .59 1.21 (0.61–2.41) 1.32 (0.55–2.2) .27
Birth weight
(mean  SD) (g)c
3,178.5  562.2 3,302.8  542.5 .38 0.99 (0.98–1.0) 0.99 (0.98–1.0) 3,321.4  524.8 3,391.1  565.4 .29 1.0 (1.0–1.0) 1.0 (0.9–1.1)
IUGR 18 23.1 6 2.6 < .001 11.4 (4.34–30.0) 9.2 (4.99–21.9) 12 5.3 12 1.8 .007 3.11 (1.38–7.03) 3.0 (1.77–5.2) .04
Low birth weight
(<2,500 g)
12 15.4 12 5.1 .006 3.36 (1.44–7.84) 3.99 (1.78–7.11) 18 7.9 24 3.5 .01 2.36 (1.26–4.43) 2.1 (1.55–4.0) .69
Very low birth
weight (<1,500 g)
0 0 0 0 –d –d –d 0 0 6 0.9 .35 1.00 (1.00–1.02) 0.89 (0.78–1.2) –d
NICU admission 0 0.00 18 7.7 .009 0.92 (0.89–0.96) 0.34 (0.11–0.61) 12 5.3 24 3.5 .24 1.53 (0.75–3.11) 1.9 (0.66–2.81) .10
Male sex 42 53.8 114 48.7 .51 1.23 (0.74–2.05) 1.1 (0.81–1.89) 132 57.9 282 41.2 < .001 1.96 (1.45–2.66) 1.4 (1.2–1.9) .12
Congenital
malformations
6 7.7 18 7.7 1.00 1.00 (0.38–2.62) 1.00 (0.55–1.5) 6 2.6 18 2.6 1.00 1.00 (0.39–2.55) 1.00 (0.22–2.90) 1.00
Note: All variables were adjusted for age, body mass index, parity, chronic maternal diseases and obstetric history data: miscarriage, termination of pregnancy, fetal loss in the second trimester, hypertensive disorder, prematurity, and IUGR fetus in previous pregnancies.
CI ¼ conﬁdence interval; ICSI ¼ intracytoplasmic sperm injection; IUGR ¼ intrauterine growth restriction; IVF ¼ in vitro fertilization; NICU ¼ neonatal intensive care unit; OR ¼ odds ratio; SD ¼ standard deviation.
a P value, odds ratio, and 95% CI for comparison of categorical data with Fisher's exact test or chi-square test.
b P value for the Mantel-Haenszel test.
c Continuous variables displayed as mean  SD. Comparison of continuous data in two distinct years with Mann-Whitney U test.
d Statistical analysis was not meaningful.
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TABLE 4
Logistic regression models on presenting risk factors of vanishing
twin pregnancies achieved by in vitro fertilization or natural
conception presented at the Department of Obstetrics and
Gynecology, University of Szeged, between January 1, 1994, and
November 30, 2014.
Logistic regression model of
vanishing twin pregnancies AOR (95% CI)a P valuea
By in vitro fertilization
(n ¼ 312)
GDM in the previous
pregnancy
5.41 (1.36–21.7) .017
Chronic maternal
diseases
3.48 (1.27–9.60) .016
GDM in the present
pregnancy
2.33 (1.14–4.55) .021
Placental abruption 4.35 (1.31–22.8) .020
Retained placenta 8.00 (2.74–23.3) < .001
IUGR 28.2 (2.18–14.5) < .001
By natural conception
(n ¼ 912)
Chronic maternal
diseases
2.10 (1.39–3.34) < .001
IUGR 3.65 (1.43–8.5) .006
Note: Both logistic regression models were adjusted for maternal age and body mass index,
parity, chronic maternal diseases, and obstetric history data: miscarriage, termination of
pregnancy, fetal loss in the second trimester, hypertensive disorder, prematurity, and
small-for-gestational-age/growth retarded fetus in the previous pregnancies. GDM ¼ gesta-
tional diabetes mellitus; IUGR ¼ intrauterine growth restriction.
a P value, adjusted odds ratio (AOR), and 95%conﬁdence interval (CI) for comparison ofmul-
tiple logistic regression.
Marton. Pregnancy outcome of vanishing twin. Fertil Steril 2016.
Fertility and Sterility®confounders. Our most striking result is that the resorption of
an embryo induces growth restriction in the remaining twin,
particularly after IVF–ICSI, as compared with age- and previ-
ous gestation-matched singletons. This observation has been
a consistent ﬁnding in other reports (2,8,9,28–30). After IVF–
ICSI, the odds of a birth weight <10th percentile greater than
9 times and 4-fold odds for low birth weight were observed,
whereas the respective ﬁgures for natural conception were
only 3.1 and 2.4. One reason for this difference may be that
the VT phenomenon in IVF–ICSI pregnancies was detected
at a greater gestational length, suggesting that reduction
occurs at a later stage. Later timing of the demise of a
cotwin in IVF–ICSI might indicate that it is not the quality
of the vanished embryo that is the dominant factor but the
uterine environment (7, 10) or the impaired utero-fetal inter-
action of the developing cotwin with possibly normal growth
potential (23).
One can speculate that the larger fetoplacental tissue re-
quires a longer elimination process (31), resulting in a poorer
obstetric outcome (2, 8). During restoration, the remodeling of
the fetoplacental blood ﬂow might be driven by
decomposition products from the vanishing fetus. Hence,
blood ﬂow toward the surviving twin might be decreased
temporarily, inducing a relative placental insufﬁciency that
could delay placental expansion and retard fetal growth.
It is interesting that we did not ﬁnd that the vanishing
fetus had any signiﬁcant inﬂuence on the rate of preterm
birth either in the IVF–ICSI group or in the spontaneous
group, a result that contrasts with other epidemiologic and
observational studies (2, 11) but conﬁrms still other studiesVOL. 106 NO. 6 / NOVEMBER 2016(18, 30). One intriguing ﬁnding was that we did not ﬁnd
any low birth weight or very preterm births in our VT
groups. Our study provides evidence that adverse outcomes
of VT pregnancies are more likely to be associated with the
greater odds of lower birth weight and an increased
proportion of age-related morbidities, which are usually
more common in IVF pregnancies (32).
Cases of pregestational and gestational diabetes are
noticeably more common among VT pregnancies achieved
by IVF–ICSI. One potential reason could be that two placentas
exceed the uterine capacity, resulting in ‘‘crowding’’ (6),
because placentomegaly and relative uteroplacental insufﬁ-
ciency (33) develop rather early in diabetic pregnancies.
Diabetes-generated teratogens might also induce miscarriage
(34), which might even lead to the loss of one infant from a
pair of twins possibly due to the uneven susceptibilities of
the fetuses. In accordance with other studies (8, 10), we
found that placental dysfunction caused by hypertensive
disorders appears not to determine the outcome of VT
pregnancies considerably because essential hypertension is
extremely uncommon. There does not seem to be any link
between VT and preeclampsia.
Placental factors may also contribute to these adverse
outcomes because placental insertion abnormalities such as
placenta previa and retained placenta are associated with
VT. Moreover, the IVF–ICSI technique promotes higher rates
of these anomalies (32). This observation corroborates the
ﬁnding that impaired placentation at an inappropriate uterine
site (6) might have a putative effect on the single loss in twins
particularly after IVF–ICSI.
In line with the concept that twinning frequency in-
creases with maternal age (32, 35), we found that the VT
phenomenon is also associated with advanced age in both
groups, as documented by others in IVF–ICSI pregnancies
(7, 12). Because aging decreases oocyte quality, which is the
strongest predictor of embryo potential (36), it might be
assumed that genetically impaired oocytes implant
particularly after natural conception. One advantage of our
study is that pregnancies resulting from ovulation induction
or insemination were excluded, as these procedures increase
the risk of VT among twins by up to 38% (7). Miscarriage-
related risk factors such as obesity and smoking do not
seem to play a role in VT because of the possible effect on
both conceptions. Nor does it appear that cavity deformities
such as congenital uterine anomalies count for VT.
Our study has some limitations. The relatively low inci-
dence of VT denotes the low power of the statistical analyses,
particularly when confounders were considered in multiple
statistical analyses. Theoretically, the rate of VT pregnancies
after IVF–ICSI depends on the rate of multiple embryo trans-
fer. Furthermore, the study spans more than two decades in
which ART has improved dramatically, and the focus was
not on procedure speciﬁcs (i.e., fresh vs. frozen ET or IVF
vs. ICSI procedures). However, it is of note that artiﬁcial pro-
cedures have a profound effect on the splitting of the zygote
(37), which represents an unavoidable bias in the comparison
of spontaneous and IVF–ICSI VT-pregnancies. However, all
the women with VT pregnancies after IVF–ICSI underwent a
double-embryo transfer procedure, and all the monochorionic1405
ORIGINAL ARTICLE: EARLY PREGNANCYtwin pregnancies were excluded from both of the study
groups. We further assume that the absorption of an embryo
in a monochorionic twin pregnancy could also lead to the
elimination of the remaining cotwin at a high rate.
In conclusion, it appears that different pathologic pro-
cesses might cause VT and eliminate the fetoplacental unit
in a different uterine environment, thus exhibiting a trend to-
ward higher rates of perinatal complications in IVF–ICSI
pregnancies compared with those conceived spontaneously.
Spontaneous reduction occurs more frequently in sponta-
neous twin pregnancies than in conceptions after assisted
reproduction. The main ﬁndings of the high rate of IUGR ne-
onates in connection with certain maternal illnesses is related
to adverse perinatal outcomes in VT pregnancies. For further
consistency, prospective epidemiologic studies are necessary
to investigate the role of less prevalent miscarriage-related
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